Soloff M S, Schroeder B T, Chakraborty J, Pearlmutter A F
Fed Proc. 1977 May;36(6):1861-6.
High affinity binding sites for 3[H] oxytocin have been demonstrated in particulate fractions from rat uterus and oviduct, myometrium from the sow, ewe and human, ewe endometrium, and mammary gland from the lactating rat. The binding activity has been localized to enriched plasma membrane fractions from the rat uterus and mammary gland; cells isolated from the mammary gland also bind oxytocin. The apparent dissociation constant (Kd) for the interaction of oxytocin with its binding sites in a variety of tissue preparations is in the nanomolar range. The concentration of oxytocin eliciting half-maximal contraction of the rat isolated uterus corresponds to the apparent Kd of oxytocin interaction with uterine particulate fractions. Binding is specific with respect to the target tissue or cell, as well as to the ligand. The affinity of binding sites for oxytocin analogues corresponds generally to their potencies as agonists or antagonists. Factors that affect the binding of oxytocin affect the biological response in the same way. For example, certain divalent metal ions, which increase oxytocin binding activity, enhance the sensitivity of the contractile response of the uterus and mammary gland to oxytocin. Estrogen administration, which increases the uterine binding of oxytocin, increases the sensitivity of the myometrium to oxytocin. The myometrium binds the most oxytocin at estrus and is most sensitive to oxtocin at that time. The dgree of stimulation by oxytocin of prostaglandin F2alpha synthesis by ewe endometrium is paralleled by an increased concentration of oxytocin binding sites. The marked increase in sensitivity to oxytocin of the rat uterus occurring on the day of parturition also is reflected by the amount of oxytocin bound by the uterus. Because of the many correlations between oxytocin binding and bioactivity, it appears that oxytocin binding sites on the plasma membrane of target cells constitute the recognition part of oxytocin receptors.
在大鼠子宫和输卵管、母猪、母羊和人类的子宫肌层、母羊子宫内膜以及泌乳大鼠的乳腺的微粒体部分中,已证实存在3[H]催产素的高亲和力结合位点。结合活性已定位到大鼠子宫和乳腺富含质膜的部分;从乳腺分离的细胞也能结合催产素。在各种组织制剂中,催产素与其结合位点相互作用的表观解离常数(Kd)处于纳摩尔范围。引起大鼠离体子宫半数最大收缩的催产素浓度与催产素与子宫微粒体部分相互作用的表观Kd相对应。结合对于靶组织或细胞以及配体具有特异性。催产素类似物结合位点的亲和力通常与其作为激动剂或拮抗剂的效力相对应。影响催产素结合的因素以相同方式影响生物学反应。例如,某些二价金属离子可增加催产素结合活性,增强子宫和乳腺对催产素收缩反应的敏感性。给予雌激素可增加子宫对催产素的结合,增加子宫肌层对催产素的敏感性。子宫肌层在发情期结合的催产素最多,此时对催产素最敏感。母羊子宫内膜中催产素刺激前列腺素F2α合成的程度与催产素结合位点浓度的增加平行。大鼠子宫在分娩日对催产素敏感性的显著增加也反映在子宫结合的催产素量上。由于催产素结合与生物活性之间存在许多相关性,看来靶细胞质膜上的催产素结合位点构成了催产素受体的识别部分。